| Metric | Q1'27 | Q2'27 | Change |
|---|---|---|---|
| Revenue | $479 M, +31% YoY | $508 M, +30% YoY | +$29 M (+6%) |
| GAAP EPS | $0.08, positive | $0.03, positive | -$0.05 (‑63%) |
| Non‑GAAP Operating Margin | 19% YoY | 21% YoY | +200 bps |
| Free Cash Flow Margin | 15% YoY | 13% YoY | -200 bps |
| ARR (Total) | $2.0 B, +30% YoY | $2.1 B, +30% YoY | +$100 M |
| Net New ARR | $101 M, +30% YoY | $134 M, +28% YoY | +$33 M |
| ARR > $100k cohort | $1.2 B, +37% YoY | $1.3 B, +38% YoY | +$100 M |
| ARR > $1 M cohort | $500 M, +62% YoY | $>500 M, +50% YoY (3‑Q streak) | Stable‑high growth |
| Emerging‑product contribution | ≈20% of net new ACV, Q1 | ≈20% of net new ACV, Q2 | Flat - no acceleration |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.